Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003468434 | SCV004214270 | likely pathogenic | Congenital myasthenic syndrome 4A | 2023-03-15 | criteria provided, single submitter | clinical testing | |
Palindrome, |
RCV004775408 | SCV005382624 | pathogenic | Congenital myasthenic syndrome 4B | 2024-07-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003468434 | SCV005767771 | pathogenic | Congenital myasthenic syndrome 4A | 2024-02-26 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu70Hisfs*3) in the CHRNE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CHRNE are known to be pathogenic (PMID: 22678886). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CHRNE-related conditions. For these reasons, this variant has been classified as Pathogenic. |